000 01740 a2200493 4500
005 20250516150200.0
264 0 _c20140218
008 201402s 0 0 eng d
022 _a1557-7422
024 7 _a10.1089/hum.2012.205
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrossardt, Christian
245 0 0 _aGranulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.
_h[electronic resource]
260 _bHuman gene therapy
_cJul 2013
300 _a644-54 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdaptive Immunity
_ximmunology
650 0 4 _aAdenocarcinoma
_xgenetics
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aChlorocebus aethiops
650 0 4 _aColonic Neoplasms
_xgenetics
650 0 4 _aEnzyme-Linked Immunospot Assay
650 0 4 _aGenetic Engineering
_xmethods
650 0 4 _aGranulocyte-Macrophage Colony-Stimulating Factor
_xgenetics
650 0 4 _aImmunohistochemistry
650 0 4 _aL-Lactate Dehydrogenase
_xmetabolism
650 0 4 _aMeasles virus
_xgenetics
650 0 4 _aMice
650 0 4 _aOncolytic Virotherapy
_xmethods
650 0 4 _aOncolytic Viruses
_xgenetics
650 0 4 _aVero Cells
700 1 _aEngeland, Christine E
700 1 _aBossow, Sascha
700 1 _aHalama, Niels
700 1 _aZaoui, Karim
700 1 _aLeber, Mathias F
700 1 _aSpringfeld, Christoph
700 1 _aJaeger, Dirk
700 1 _avon Kalle, Christof
700 1 _aUngerechts, Guy
773 0 _tHuman gene therapy
_gvol. 24
_gno. 7
_gp. 644-54
856 4 0 _uhttps://doi.org/10.1089/hum.2012.205
_zAvailable from publisher's website
999 _c22722524
_d22722524